EY-Parthenon adds trio of partners to private equity practice
EY-Parthenon, the strategy consulting subsidiary of Big Four giant EY, has appointed three new Europe-based partners in its Private Equity practice.
The duo of Georg Hochleitner and Malvinder Singh both join from Alvarez & Marsal. Hochleitner had served the firm for four years, and previously was a partner at German strategy boutique goetzpartners. Before that, he held roles at financial advisory specialist Rothgordt & Cie. and Bain & Company, among others. He specialises in commercial and operational due diligence as well as in post-acquisition value creation.
Singh worked for Alvarez & Marsal in the United Kingdom for nearly seven years, having previously served United Business Media and Big Four firm PwC. He specialises in technology and digital transformation services, and will at EY-Parthenon focus on technology due diligence pre-deal, and IT integration post-deal.
Simon Oertel transfers to EY-Parthenon – which launched in 2014 globally after EY acquired The Parthenon Group – from Oliver Wyman. He spent thirteen years at Oliver Wyman, where he delivered projects across Europe, Russia, the Middle East and the United States. He advises primarily private equity clients across the entire transaction life cycle, from pre-deal target assessments to post-deal value creation work, with a focus on manufacturing industries.
Commenting on the hires, Stephane Baleston, EY-Parthenon’s Private Equity Leader for the EMEIA region, said: “Our number one goal is to continue to grow our team in order to best support our private equity clients realise the potential of their investments across EMEIA. I am very excited to have Georg, Malvinder and Simon join our team.”
The appointment comes during a time of rebound for private equity-backed M&A. Following a slump in activity after the Covid-19 pandemic kicked in, investors and family offices have returned to the scene, putting more of their dry powder to work and re-aligning their portfolios to meet the changing demands of the new normal.